Introduction
Historically, phenobarbital is one of the first antiepileptic medications used in the field since the early 1900s. During the past decades, phenobarbital, carbamazepine and sodium valproate were the main non-benzodiazepine antiepileptics used with few mortalities; as many centers now also use newer antiseizure medications [1] . It is well known that this drug has soporific, sedative, and hypnotic properties. As a result, the prominent feature of phenobarbital overdose is cortical suppression and coma. It may seem surprising if a patient develops seizure in presence of high blood levels of phenobarbital. Hereby, we present a patient who had attempted suicide with phenobarbital and presented to us with status epilepticus. Written informed consent was obtained from him after regaining consciousness.
Case study
A 45-year-old man was referred to us after he was found in deep coma. He had a positive history of epilepsy for 27 years and a history of head trauma at age 40 without any serious consequences. His relatives had found an empty bottle of phenobarbital pills with him and therefore, suicidal attempt was suspected.
No evidence of recent trauma or vomiting was present. He was on sodium valproate (200 mg, TDS), phenytoin (100 mg, TDS), and phenobarbital (50 mg, QID) for 26 years because of idiopathic generalized tonic-clonic seizures. His childhood was eventless (without any history of febrile convulsions, meningitis, or prolonged icterus). His parents did not mention any episode of status epilepticus or non-convulsive seizures. He was on sodium valproate, phenytoin, and phenobarbital to control his generalized tonic-clonic seizures.
The patient's Glasgow Coma Scale (GCS) was three when the paramedics arrived at the scene. They intubated and transferred him to our center. On presentation to our emergency department, his vital signs were stable, he was afebrile and unresponsive to all stimuli, his pupils were normal sized and reactive, oculocephalic and corneal reflexes were absent, and plantar reflexes were neutral.
Brain computed tomography was normal. On toxicology screening, phenobarbital level was as high as 180 mg/mL while valproate and phenytoin levels were 10 and 1.7 mg/mL, respectively. Laboratory results were negative for other drugs. Activated charcoal was given and urine alkalization was performed but failed to improve him. Hemodialysis was therefore performed which was again unsuccessful. On electroencephalogram (EEG), continuous epileptiform discharges (generalized polyspike and wave on a slow background) were present in favor of non-convulsive status epilepticus (Fig. 1) . To control the subclinical seizure, sodium valproate (25 mg/kg) and midazolam (5 mg/h) were administered intravenously. He underwent two more sessions of hemodialysis due to high levels of phenobarbital (183 and 85 mg/mL) and antiepileptic therapy as well as daily EEG. Epileptic discharges disappeared eventually and the patient became fully conscious in seven days. He was extubated and left the hospital against medical advice after performance of psychiatry consultation.
Discussion
Nowadays, several safe antiepileptic drugs are introduced limiting the indications for phenobarbital prescription. However, the drug still has its own market with high rate of hospitalization in cases of toxicity because of being a potent solution in status epilepticus and a favorable choice in children. Its anticonvulsive mechanism is thought to be through the effect on gammaaminobutyric acid (GABA) receptors leading to increased chloride influx and neuronal inhibition [2] .
Instances of precipitated seizures caused by different antiepileptic drugs including GABAergic drugs are repeatedly reported. Phenobarbital may cause paradoxical reaction in children with atypical benign rolandic epilepsy, epileptic negative myoclonus, and diffuse interictal sharp and slow wave discharges. This may be coupled with activation of continuous spike-wave discharges over the central head region during sleep [3] . In adults, one case of nonconvulsive status epilepticus accompanying phenobarbital toxicity was reported by Marioni et al. [4] . Different speculations have been made in this regard. Some authorities suggest non-convulsive status cases may have simply implied drug-induced or hypoxic encephalopathy, not necessarily increased epileptic activity. However, in our case, EEG shows continues polyspike discharges throughout the cortex. This is in contrast to generalized slowing without obvious epileptic activity which is the dominant electroencephalographic feature of aforementioned encephalopathies.
On the other hand, some studies have shown that molecular factors of some barbiturates may play role in their convulsive effects, as different enantiomers have opposite effects on the neuronal circuit. As for other GABAergic drugs, interaction with thalamocortical pathways might also be involved in the pathogenicity [2, 3] . Nevertheless, due to ethical issues, inability to conduct satisfactory trials makes the present data anecdotal. Only a CT and no MRI brain was done, and therefore minor hypoxic ischemic injury, tentatively due to respiratory compromise after phenobarbital ingestion, cannot be entirely ruled out and should be more clearly discussed. Thus additional research in this field can even improve our understanding of phenobarbital-induced epilepsy.
Conclusion
Seizure aggravation can be induced by phenobarbital toxicity. An electroencephalographic evaluation seems reasonable in cases of phenobarbital poisoning to detect underlying seizure and manage it properly. More studies are still warranted to clarify the exact mechanism of such events.
